S D Shorvon
Overview
Explore the profile of S D Shorvon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
204
Citations
3699
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies
Shorvon S, Trinka E, Steinhoff B, Holtkamp M, Villanueva V, Peltola J, et al.
J Neurol
. 2017 Jan;
264(3):421-431.
PMID: 28101651
Eslicarbazepine acetate (ESL) is a once-daily antiepileptic drug that is approved as adjunctive therapy in adults with focal-onset seizures. Following oral administration, ESL is rapidly metabolized to its active metabolite,...
2.
Neligan A, Bell G, Giavasi C, Johnson A, Goodridge D, Shorvon S, et al.
Neurology
. 2012 Mar;
78(15):1166-70.
PMID: 22459683
Objective: We report the prospective follow-up of a cohort of people from the onset of febrile seizures for a median of 24 years to estimate the long-term risk of developing...
3.
Neligan A, Shorvon S
Epilepsy Res
. 2010 Oct;
93(1):1-10.
PMID: 20947300
Objectives: to determine how the duration of SE, the EEG findings during/after SE, the depth of coma at presentation and age impact on the prognosis of convulsive status epilepticus indepedent...
4.
Dellaportas D, Shorvon S, Galbraith A, Laundy M, Reynolds E, Marshall W, et al.
Br Med J (Clin Res Ed)
. 2010 Aug;
285(6339):409-10.
PMID: 20741873
No abstract available.
5.
Tan R, Neligan A, Shorvon S
Epilepsy Res
. 2010 Aug;
91(2-3):111-22.
PMID: 20709500
This paper reports the first systematic review of uncommon causes of status epilepticus reported in the literature between 1990 and 2008. Uncommon causes are defined as those not listed in...
6.
Tiamkao S, Shorvon S
Hong Kong Med J
. 2006 Aug;
12(4):260-3.
PMID: 16912351
Objective: To assess the frequency, characteristics, and risk of injury during seizure attacks. Design: Questionnaire survey. Setting: Epilepsy out-patient clinic of the National Hospital for Neurology and Neurosurgery, Institute of...
7.
Shorvon S
J Neurol Neurosurg Psychiatry
. 2004 Oct;
75(11):1517-8.
PMID: 15489379
No abstract available.
8.
Moran N, Poole K, Bell G, Solomon J, Kendall S, McCarthy M, et al.
Seizure
. 2004 Jul;
13(6):425-33.
PMID: 15276147
Objectives: To describe the clinical characteristics of epilepsy in a representative sample of the UK population, including seizure frequency and severity; overall severity of epilepsy; patterns of anti-epileptic drug (AED)...
9.
Liu R, Lemieux L, Bell G, Sisodiya S, Shorvon S, Sander J, et al.
Neuroimage
. 2003 Oct;
20(1):22-33.
PMID: 14527567
Serial quantitative magnetic resonance imaging (MRI) allows the detection of subtle volumetric changes in brain volume. We used serial volumetry and voxel-based difference image analysis to quantify and characterize longitudinal...
10.
Hagemann G, Lemieux L, Free S, Krakow K, Everitt A, Kendall B, et al.
J Neurol
. 2003 Jan;
249(12):1651-8.
PMID: 12529786
Cerebellar atrophy is assumed to be a common finding in patients suffering from epilepsy. Anticonvulsants as well as seizure activity itself have been considered to be responsible for it but...